A former Intuitive Surgical executive has argued that the company’s principal competitive advantage lies in the depth of its training infrastructure, not solely in the Da Vinci robotic hardware. The executive said rivals such as Johnson & Johnson and Medtronic are several years behind in developing equivalent training systems, lagging by an estimated five to ten years.
The former Vice President of Clinical Sales at Intuitive Surgical (NASDAQ:ISRG) told reporters that surgeons who perform 13 cases within their first 90 days on the platform demonstrate better than a 90% probability of continuing to use Da Vinci systems. The executive also said that medical residents now train on Da Vinci equipment from the beginning of their education, and that hospitals have been reluctant to hire urologists who lack Da Vinci experience.
Intuitive Surgical shares are trading at $477.54. Analysts covering the company forecast 29.3% earnings per share growth for 2026 and have set a price target of $605.08, which represents approximately 31% upside from the current share price cited. The company reported second-quarter 2025 revenue of $2.44 billion, an increase of 21% year over year, and noted global procedure volume rose 20%.
Operating in more than 74 countries, Intuitive Surgical has supported over 17 million procedures across its Da Vinci and Ion platforms. The company’s latest Da Vinci 5 system, which incorporates force feedback and enhanced digital integration, is being adopted more widely around the world. Revenue growth for 2026 is forecast at 14.3%.
The executive’s comments emphasize behavioral and educational dynamics - early hands-on experience, residency exposure, and hiring preferences - as reinforcing adoption of the company’s systems. Those dynamics, coupled with reported top-line expansion and rising procedure counts, form the financial context cited in analyst forecasts and price targets.
Summary
The company’s training network and clinician onboarding processes are presented as its primary moat, supported by surgeon retention metrics, widespread residency training, and hiring practices that favor Da Vinci experience. Financial results and analyst projections indicate accelerating growth in revenue, procedures and expected earnings.